Olav Wendelboe Nielsen

Medicine & Life Sciences

1. Liraglutide 100%
2. Coronary Artery Disease 71%
3. Heart Failure 63%
4. Systemic carnitine deficiency 60%
5. Aortic Valve Stenosis 53%
6. Ezetimibe 50%
7. Placebos 47%
8. Brain Natriuretic Peptide 47%
9. Type 2 Diabetes Mellitus 45%
10. Simvastatin 43%
11. Hypokalemia 42%
12. Carnitine 40%
13. Cross-Over Studies 35%
14. Mortality 35%
15. Denmark 32%
16. Stroke 32%
17. Atrial Premature Complexes 30%
18. Troponin T 28%
19. Continuous Positive Airway Pressure 28%
20. Myocardial Infarction 27%
21. Atrial Fibrillation 27%
22. Glucagon-Like Peptide-1 Receptor 25%
23. Confidence Intervals 25%
24. Sleep Apnea Syndromes 25%
25. Stroke Volume 25%
26. Heart Rate 25%
27. Computed Tomography Angiography 24%
28. Aortic Valve 24%
29. Independent Living 24%
30. Cardiology 24%
31. Coronary Angiography 22%
32. Metformin 21%
33. Cohort Studies 20%
34. Population 20%
35. Exercise 20%
36. Datasets 19%
37. Blood Pressure 19%
38. pro-brain natriuretic peptide (1-76) 18%
39. Glucagon-Like Peptides 18%
40. PTX3 protein 18%
41. Biguanides 17%
42. Chymases 16%
43. Elderly 16%
44. Glucose 16%
45. Nitrogen Dioxide 16%
46. Potassium 16%
47. Randomized Controlled Trials 16%
48. Systolic Heart Failure 16%
49. Therapeutics 15%